Clinical Trials Browser

Phase 2 × INDUSTRY × Leukemia, Promyelocytic, Acute × Clear all

NCT00520208 2013-02-13

STAR-1

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT01018069 2011-07-13

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute